Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Milano

Showing results (231-240 of 347) with videos related to

Pageof 35
Sort By:
Clinical and Diagnostic Laboratory Immunology|May 10, 2005
Enzyme-linked immunosorbent assay for pharmacological studies targeting hypoxia-inducible factor 1alphaJ L Formento, E Berra, B Ferrua, et al.
Archives of Family Medicine|March 31, 1998
Religious commitment and health status: a review of the research and implications for family medicineD A Matthews, M E McCullough, D B Larson, et al.
British Journal of Cancer|May 1, 1994
Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamilA M Julia, H Roché, M Berlion, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 1, 2014
Uncorrected Ebstein's anomaly with atrial septal defect complicated by brain abscess in an adult patientRoberto Scarsini, Maria A Prioli, Elena G Milano, et al.
British Journal of Cancer|July 14, 1998
Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivityJ F Mirjolet, M Barberi-Heyob, J L Merlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenograftsJ Ciccolini, L Peillard, A Evrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-upJ M Ferrero, A Ramaioli, R Largillier, et al.
Head & Neck|September 1, 1993
Sedimentation rate and serum thymidine kinase activity: prognostic factors in squamous cell head and neck cancerX Fontana, O Dassonville, J Néri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Doxorubicin weekly low dose administration: in vitro cytotoxicity generated by the typical pharmacokinetic profileG Milano, E Cassuto-Viguier, J L Fischel, et al.
Clinical Pharmacology and Therapeutics|July 20, 2007
Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patientsM-C Etienne-Grimaldi, J-M Cardot, E François, et al.
Pageof 35

Showing results (231-240 of 347) with videos related to

Sort By:
Pageof 35
Clinical and Diagnostic Laboratory Immunology|May 10, 2005
Enzyme-linked immunosorbent assay for pharmacological studies targeting hypoxia-inducible factor 1alphaJ L Formento, E Berra, B Ferrua, et al.
Archives of Family Medicine|March 31, 1998
Religious commitment and health status: a review of the research and implications for family medicineD A Matthews, M E McCullough, D B Larson, et al.
British Journal of Cancer|May 1, 1994
Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamilA M Julia, H Roché, M Berlion, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 1, 2014
Uncorrected Ebstein's anomaly with atrial septal defect complicated by brain abscess in an adult patientRoberto Scarsini, Maria A Prioli, Elena G Milano, et al.
British Journal of Cancer|July 14, 1998
Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivityJ F Mirjolet, M Barberi-Heyob, J L Merlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenograftsJ Ciccolini, L Peillard, A Evrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-upJ M Ferrero, A Ramaioli, R Largillier, et al.
Head & Neck|September 1, 1993
Sedimentation rate and serum thymidine kinase activity: prognostic factors in squamous cell head and neck cancerX Fontana, O Dassonville, J Néri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Doxorubicin weekly low dose administration: in vitro cytotoxicity generated by the typical pharmacokinetic profileG Milano, E Cassuto-Viguier, J L Fischel, et al.
Clinical Pharmacology and Therapeutics|July 20, 2007
Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patientsM-C Etienne-Grimaldi, J-M Cardot, E François, et al.
Pageof 35